Early Findings on Characterizing Decision-Making in Dementia and Among Dementia Gene Carriers

Winston Chiong, MD, PhD
Professor of Neurology
‌Director of UCSF Bioethics
University of California, San Francisco

Learning Objectives

• Assess methodological challenges in the measurement and interpretation of decision-making alterations among clinical populations.
• Identify new approaches to characterizing decision-making in people with dementia and in people who carry dementia-associated genes.

Disclosures

• Planners: Bruce L. Miller, MD, serves on NKGen Biotech, Inc.'s Scientific Advisory Board. Howard J. Rosen, MD, Anil Vora, and Laura Wise have stated that they have no relationships with ineligible companies to disclose.
• Speaker: Winston Chiong, MD, PhD, has stated he has no relationships with ineligible companies to disclose.

Accreditation: In support of improving patient care, this activity has been planned and implemented by UCSF Office of CME and the Edward and Pearl Fein Memory and Aging Center. UCSF Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 
‌
‌This CME activity meets the requirements under California Assembly Bill 1195 for continuing education and cultural and linguistic competency.

Designation: UCSF designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit is inclusive of all Edward and Pearl Fein Memory and Aging Center Grand Rounds sessions offered from January 1, 2026, through December 31, 2026. (1 credit per each 1-hour grand rounds session throughout the year).

Virtual attendees must register for this event. Grand Rounds presentations are for educational purposes and intended for a professional audience with a terminal degree. This activity is not commercially supported.